ApprovalTrail

Approval · Notice of Compliance 4533 · 1996

APO-MEFENAMIC: Notice of Compliance 4533

Issued October 25, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4533
Date
October 25, 1996
Company
Apotex Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Analgesic

Products in this notice

BrandDINStatus today
APO-MEFENAMIC02229452Marketed

Medicinal ingredients